All In Biotech

Drug Trial Radar · NCT04522739

Spironolactone Safety in African Americans With Mild Cognitive Impairment and Early Dementia

Last checked: Nov 20, 2026Latest source record: Nov 20, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

27

Actual

Start

Sep 6, 2022

Primary completion

Sep 23, 2025

Study completion Sep 23, 2025

Sponsor

Lead sponsor
Emory UniversityAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Alzheimer's Association
First posted
Aug 21, 2020

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Prevention
FDA-regulated drug
Yes
Who can join
All sexes, from 50 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to investigate whether a blood pressure medication, spironolactone, can be tolerated by older African American adults that have memory and thinking problems, also called mild cognitive impairment (MCI). This study will also investigate the effect of spironolactone on memory and thinking abilities as measured by performance on cognitive tests, which are tests that measure memory and thinking skills. Participants will take spironolactone or a placebo for one year and will have 4 to 5 study visits during the study period.

Conditions

  • Mild Cognitive Impairment
  • Alzheimer Disease

Interventions

  • SpironolactoneDrug

    Study participants will receive a 25 mg dose of spironolactone. Participants will take one capsule by mouth per day for 12 months.

  • PlaceboDrug

    A placebo to match spironolactone will be taken orally once per day for 12 months.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Count of Adverse EventsTime frame: Month 12
  2. Number of Participants Not Completing The StudyTime frame: Month 12

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Emory Clinic at Executive Park

    Atlanta, Georgia

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.